The Global Leadless Pacemakers Market is poised to value over USD 51.3 million during the forecast period 2022 to 2028.
Pacemakers were invented in the 1950s with the primary goal of treating life-threatening heart blockages caused by cardiac surgery. Though these devices extended life, they were plagued by a number of drawbacks, including a short battery life, lead failure, and infections caused by surgery. Many of the same problems exist in today’s left ventricular assisted pacemaker devices. With technological advancements, the size of pacemakers has shrunk significantly, allowing the first pacemaker to be implanted in Sweden in 1958. Parsonnet etal invented and first used the trans-venous lead in pacemaker devices. These early pacemakers were only capable of asynchronous pacing and had limited functionality. Rapid advances in pacemaker technology, including rate and output, have allowed noninvasive communication with devices, and improved battery technology has allowed the pulse generator’s life span to be extended by one year. Trans-venous cardiac pacemakers have extended patients’ lives and reduced their mortality. These pacemakers, however, are still associated with a number of potential device-related complications. It is estimated that 10% of patients have complications from trans-venous pacemaker implantation. Traditional pacemakers are dependable, but they have many limitations due to the subcutaneous pocket where pacemakers are placed. These can cause skin erosion. Trans-venous lead use can result in pneumothorax or deep vein thrombosis. There are two types of leadless pacemakers: single chambered and double chambered. Until now, approximately five million conventional pacemakers have been implanted worldwide, with nearly 20% of these cases failing annually due to lead wiring. The global leadless pacemaker market is being driven by an increase in the geriatric population, an increase in the incidence of cardiovascular disorders, technological advancements, an increase in health care expenditure, and an increase in favourable government reforms promoting health care facilities. Furthermore, other factors such as the absence of harmful lead, the absence of infections and scarring, MRI compatibility, and the absence of postoperative mobility restrictions are expected to drive the global leadless pacemaker market. However, factors such as insufficient personnel to perform procedures, reimbursement issues, and high implantation costs are expected to drive the global leadless pacemaker market. Leadless pacemakers cost roughly four times as much as conventional pacemakers.
The astute research report on Leadless Pacemakers market provides intricate details for analyzing appropriate parameters and valuable insights. The report offers extensive information about this business to help bring forth the growth potential of the market across various segments and provides the clients with a comprehensive analysis of factors like market size, market growth trends, competitive landscape, product utilization, regional growth prospects, and application potential, etc. The data provided in the report has been gathered from a wide variety of sources by using primary and secondary research. This Leadless Pacemakers research report also provides crucial insights into consumer behaviour, brand positioning, pricing analysis, and key player strategies. The market overview included in the Leadless Pacemakers research report incorporates critical factors procured from industry analysts, prominent players as well as trade and industrial organizations.
The report on Leadless Pacemakers market offers up-to-date information on the factors impeding the market growth which shall provide vendors with crucial insights into understanding the market dynamics thereby aiding the clients to sketch out a better business strategy. These factors will help them identify market growth opportunities. Furthermore, FutureWise research analysts provide timely assistance to their customers in understanding eccentric market parameters more effectively thereby leading to better decision-making.
Get a Sample of the Leadless Pacemakers Market Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=202&page=requestsample
The Leadless Pacemakers market research report is segmented – by technology, by indication, by end user, and by region. It also consists of insights regarding the revenue value and sales volume during the forecasted timeframe of 2022 to 2028.
Leadless Pacemakers Market Segmentation:
By Technology
Micra Transcatheter Pacing System
Nanostim Leadless Pacemakers
Wireless Cardiac Simulation System
By Indication
Atrial Fibrillation
High Degree Atrioventricular Block
Sinus node dysfunction
Others
By End-user
Hospitals
ASCs
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Leadless Pacemakers Market Regional Analysis:
The report provides a complete evaluation of the potential amplification of the Leadless Pacemakers Market in pivotal geographic regions such as North America, Asia Pacific, Europe, Latin America and Middle East & Africa.
Competitive Landscape:
Some of the key market players are
Medtronics
St. Jude Medical LLC (Abbott Laboratories)
Biotronic
Boston Scientific
Edwards Lifesciences
Sorin Group
Vitatron
Lepu Medical
Terumo Corp.
FutureWise Key Takeaways:
Growth prospects
SWOT analysis
Key market trends
Key data-points affecting market growth
Objectives of the Study:
To provide an extensive analysis of the global Leadless Pacemakers market by technology, by indication, by end user, and by region
To carter complex data and information on the characteristics influencing the market growth (drivers, restraints, opportunities, and industry-specific restraints)
To predict and assess micro-markets and the overall market
To anticipate the market size, in key geographical regions (along with countries)— North America, Europe, Asia Pacific, Latin America and the Middle East and Africa
To estimate and inspect competitive landscape mapping- technological advancements, product launches, mergers and expansions
Flexible Delivery Model:
Our delivery model is flexible, so you can suggest changes to the content/scope as per your requirement
With purchase of any license of the report the customization Mobility Care offered is free of charge
You can directly forward your requirements/changes to the current table of content to: sales@futurewiseresearch.com
About FutureWise Market Research:
We specialize in high-growth niche market research, offering flexibility, agility, and customized solutions for our clients. By providing our clients with market insights and consulting services, we ensure they stay on top of their industries for years to come.
FutureWise Market Research
Vinay T – Head of Business Development
Email: sales@futurewiseresearch.com
UK: +44 141 628 9353 | USA: +1 347 709 4931
Website: www.futurewiseresearch.com
